Pustular skin eruption - Causes, Treatment & When to See a Doctor

```html

What is Pustular Skin Eruption?

A pustular skin eruption is a rash that is characterized by the presence of **pustules** – small, raised lesions that contain a mixture of inflammatory cells and fluid, giving them a yellow‑white or creamy appearance. These lesions can appear anywhere on the body, may co‑alesce into larger plaques, and often evolve rapidly. While many pustular eruptions are benign and self‑limited, some signal serious underlying disease and require prompt medical attention.

In dermatology, “pustular” simply describes the physical appearance; it does not indicate an infection by bacteria, fungi, or viruses unless proven by laboratory testing. The underlying mechanism often involves an abnormal immune response, genetic predisposition, drug reaction, or an infection that triggers inflammation of the skin’s superficial layers.

Common Causes

The differential diagnosis for pustular eruptions is broad. Below are the most frequent conditions that present with pustules, grouped by category.

• Acute Generalized Pustular Psoriasis (AGPP) – a severe form of psoriasis that erupts suddenly with widespread sterile pustules on erythematous skin.
• Pustular Drug Eruption – reactions to antibiotics (e.g., sulfonamides), anticonvulsants, allopurinol, or biologic agents.
• Acneiform Pustules – typical of severe acne vulgaris or acne rosacea, often localized to the face, back, or chest.
• Folliculitis – infection or inflammation of hair follicles, commonly caused by Staphylococcus aureus.
• Staphylococcal Scalded Skin Syndrome (SSSS) – a toxin‑mediated disease in children that can present with pustular lesions before widespread desquamation.
• Impetigo – a superficial bacterial skin infection that may begin as vesicles that rupture into pustules.
• Immune‑mediated diseases – e.g., subcorneal pustular dermatosis (Sneddon‑Wilkinson disease) and IgA pemphigus.
• Viral infections – such as Molluscum contagiosum with central umbilication that can be misinterpreted as pustules, or varicella‑zoster in immunocompromised patients.
• Fungal infections – Candida intertrigo or tinea corporis can occasionally produce pustular borders.
• Neutrophilic dermatoses – e.g., Sweet’s syndrome (acute febrile neutrophilic dermatosis) which typically shows tender, erythematous plaques studded with pustules.

Associated Symptoms

Because pustular eruptions can arise from systemic diseases, other signs often accompany the rash. Common associated symptoms include:

• Fever or chills – especially in generalized pustular psoriasis, Sweet’s syndrome, or bacterial infections.
• Generalized malaise, fatigue, or myalgias.
• Joint pain or swelling (arthralgia) – seen in pustular psoriasis and some drug reactions.
• Pruritus (itching) or burning sensation at the lesion sites.
• Swollen lymph nodes (lymphadenopathy).
• Oral or genital mucosal involvement – especially with severe drug eruptions or autoimmune pustular dermatoses.
• Gastrointestinal symptoms (nausea, abdominal pain) – can accompany drug‑induced pustular eruptions.

When to See a Doctor

Most pustular eruptions are self‑limited, but several scenarios mandate prompt evaluation:

• Rapid spread of pustules over large body areas or the face.
• Fever ≥ 38°C (100.4°F) or chills accompanying the rash.
• Painful, tender lesions that interfere with daily activities.
• Signs of systemic infection: rapid heart rate, low blood pressure, confusion.
• History of recent new medication, especially antibiotics, antiepileptics, or biologics.
• Existing diagnosis of psoriasis, autoimmune disease, or immunosuppression.
• Any pustular eruption in infants or young children.
• Lesions that do not improve after 48–72 hours of topical care.

Diagnosis

Accurate diagnosis relies on a combination of clinical assessment, laboratory testing, and sometimes skin biopsy.

1. Clinical History & Physical Exam

• Duration, distribution, and evolution of lesions.
• Recent drug exposure, travel, or contact with infected individuals.
• Personal or family history of psoriasis, autoimmune disease, or immunodeficiency.
• Full skin exam to assess for involvement of mucous membranes, nails, or palms/soles.

2. Laboratory Studies

• Complete blood count (CBC) – leukocytosis may indicate infection or systemic inflammation.
• Comprehensive metabolic panel – useful for monitoring organ function before systemic therapy.
• Inflammatory markers (CRP, ESR) – often elevated in pustular psoriasis and Sweet’s syndrome.
• Microbiologic cultures:
  • Swab of pustular fluid for bacterial culture (especially if purulent, tender, or accompanied by fever).
  • Fungal scrapings or KOH prep if dermatophyte infection is suspected.
• Serologic tests (e.g., ANA, anti‑dsDNA) when autoimmune disease is in the differential.

3. Skin Biopsy

In ambiguous cases, a 4‑mm punch biopsy is the gold standard. Histopathology can differentiate:

• Neutrophilic infiltrate with subcorneal pustules (consistent with pustular psoriasis or Sneddon‑Wilkinson disease).
• Intra‑epidermal vesiculation with eosinophils (suggestive of drug eruption).
• Presence of bacterial colonies in the follicular lumen (supports folliculitis).

4. Imaging (rare)

When systemic involvement is suspected (e.g., in Sweet’s syndrome with pulmonary or gastrointestinal disease), CT or MRI may be ordered.

Treatment Options

Therapy is tailored to the underlying cause, lesion extent, and patient’s overall health.

1. General Skin Care

• Gentle cleansing with pH‑balanced, fragrance‑free cleanser twice daily.
• Avoid picking or squeezing pustules to reduce secondary infection.
• Apply non‑comedogenic, barrier‑repair moisturizers (e.g., ceramide‑containing creams) after cleansing.

2. Topical Treatments

• Topical corticosteroids (mid‑ to high‑potency) for localized inflammatory pustules.
• Topical calcineurin inhibitors** (tacrolimus, pimecrolimus) – useful on face and intertriginous areas to avoid steroid‑induced atrophy.
• Antibiotic ointments** (mupirocin, fusidic acid) for suspected bacterial folliculitis.
• Antifungal creams** (clotrimazole, terbinafine) when fungal infection is confirmed.

3. Systemic Medications

• Oral antibiotics** – e.g., dicloxacillin, cephalexin, or clindamycin for bacterial infections or severe folliculitis.
• Systemic corticosteroids** – short courses for acute drug eruptions or Sweet’s syndrome (e.g., prednisone 0.5–1 mg/kg/day).
• Acitretin or Cyclosporine** – first‑line for generalized pustular psoriasis (per Mayo Clinic).
• Biologic agents** – IL‑1 inhibitors (anakinra), IL‑17 inhibitors (secukinumab), or IL‑23 inhibitors (guselkumab) for refractory pustular psoriasis.
• Colchicine** – effective for some neutrophilic dermatoses like Sweet’s syndrome.
• Immunosuppressants** (methotrexate, mycophenolate) for autoimmune pustular conditions.

4. Adjunctive Measures

• Anti‑fever medication (acetaminophen or ibuprofen) for symptomatic relief.
• Hydration and rest – especially when systemic symptoms are present.
• Patient education on medication adherence and trigger avoidance.

Prevention Tips

While not all pustular eruptions are preventable, many risk factors can be modified:

• Medication vigilance: Review new drugs with your clinician; keep a medication diary to spot patterns.
• Skin hygiene: Shower daily, change out of sweaty clothing promptly, and keep skin dry in flexural areas.
• Avoid irritants: Use fragrance‑free detergents, avoid harsh soaps, and limit exposure to known allergens.
• Manage chronic skin conditions: Consistent treatment of psoriasis or eczema can reduce flare‑ups.
• Protective footwear: In hot, humid climates, wear breathable shoes to prevent intertriginous pustules.
• Healthy diet & weight: Obesity can worsen psoriasis; a balanced diet rich in omega‑3 fatty acids may be protective.
• Cautious sun exposure: While UV can help psoriasis, overexposure may trigger burns that become pustular.
• Immune health: Stay up‑to‑date on vaccinations (e.g., influenza, COVID‑19) to reduce infection‑driven eruptions.

Emergency Warning Signs

Seek immediate medical attention if you notice any of the following:

• Sudden fever > 38.5 °C (101.3 °F) with a rapidly spreading rash.
• Severe pain, swelling, or redness that expands quickly (possible necrotizing infection).
• Signs of sepsis: rapid heartbeat, low blood pressure, confusion, or dizziness.
• Difficulty breathing, swelling of the lips/tongue, or hives – could indicate an allergic reaction.
• Pustules that turn black, develop a foul odor, or produce excessive drainage.
• New onset of pustular eruption in a newborn or infant.
• Sudden onset of pustular lesions accompanied by chest pain, abdominal pain, or joint swelling.

Call emergency services (911 in the U.S.) or go to the nearest emergency department.

Key Take‑aways

Pustular skin eruptions range from harmless acne to life‑threatening generalized pustular psoriasis. Recognizing associated systemic signs, obtaining a thorough history, and pursuing appropriate labs or biopsy are essential steps for accurate diagnosis. Early treatment—whether topical, oral, or systemic—can curb progression, reduce discomfort, and prevent complications. When in doubt, especially with fever, rapid spread, or systemic symptoms, seek professional medical care promptly.

References:

• Mayo Clinic. “Generalized pustular psoriasis.” Updated 2023. mayoclinic.org
• American Academy of Dermatology. “Drug eruptions.” 2022. aad.org
• CDC. “Impetigo.” 2024. cdc.gov
• National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). “Psoriasis.” 2023. niams.nih.gov
• World Health Organization. “Guidelines for the management of bacterial skin infections.” 2022.
• Cleveland Clinic. “Sweet’s Syndrome (Acute Febrile Neutrophilic Dermatosis).” 2023.
• Dermatology journals: “Subcorneal pustular dermatosis – a review,” Journal of the American Academy of Dermatology, 2021.

```